James Hollingshead
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
James Hollingshead has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Carolynne J. Vaizey
Departments of Physiology
5 shared publications T. C. Dudding
The Sir Alan Parks Physiology Unit, St Mark's Hospital and Academic Institute, Middlesex, UK
5 shared publicationsR. J. Nicholls
Physiology Unit, St Mark's Hospital, Watford Road, Harrow HA1 3UJ, UK
3 shared publications- Janindra Warusavitarne
Department of Colorectal Surgery, St Mark’s Hospital , London
2 shared publications A. T. George
The Sir Alan Parks Physiology Unit St Mark's Hospital and Academic Institute Middlesex UK
1 shared publication- Alan Askari
Bedfordshire Hospitals NHS Foundation Trust, Luton, UK
1 shared publication
Latest Publications
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
778 Management of Colorectal Anastomotic leaks: The East of England Experience
Introduction: Colorectal anastomotic leaks (AL) are an unfortunate occurrence and are associated with a high mortality. The aim of this multi-centre study is to explore the different management strategies used and compare outcomes in the management of AL. Method: All patients who had an AL were included at seven hospitals across the East of England. Morbidity, mortality, and survival were compared across the different management strategies. Results: A total of 247 consecutive patients were included of which 60.3% were male and the median age was 68 (IQR 57-77). Half of patients were initially managed conservatively, a further 10.5% had a radiological procedure. 39.7% required surgery as an initial treatment. Of those who initially did not have a surgical intervention (n = 149), 10.7% (n = 16/149) eventually required laparotomy. Ultimately, 42.7% (n = 106/248) required a laparotomy. The 30- and 90-day across the entire population mortality were 3.6% and 4.9% respectively. There were no significant differences in mortality or long-terms survival between the different initial treatment modalities. Conclusions: Despite initial conservative, antibiotic and radiological intervention being successful in the majority of patients, two out of five patients will still require a laparotomy. A consensus approach is required to standardise management in these difficult scenarios.
- 1 May 2021
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (Supplement)
Open Access778 Management of Colorectal Anastomotic leaks: The East of England Experience
Introduction: Colorectal anastomotic leaks (AL) are an unfortunate occurrence and are associated with a high mortality. The aim of this multi-centre study is to explore the different management strategies used and compare outcomes in the management of AL. Method: All patients who had an AL were included at seven hospitals across the East of England. Morbidity, mortality, and survival were compared across the different management strategies. Results: A total of 247 consecutive patients were included of which 60.3% were male and the median age was 68 (IQR 57-77). Half of patients were initially managed conservatively, a further 10.5% had a radiological procedure. 39.7% required surgery as an initial treatment. Of those who initially did not have a surgical intervention (n = 149), 10.7% (n = 16/149) eventually required laparotomy. Ultimately, 42.7% (n = 106/248) required a laparotomy. The 30- and 90-day across the entire population mortality were 3.6% and 4.9% respectively. There were no significant differences in mortality or long-terms survival between the different initial treatment modalities. Conclusions: Despite initial conservative, antibiotic and radiological intervention being successful in the majority of patients, two out of five patients will still require a laparotomy. A consensus approach is required to standardise management in these difficult scenarios.
- 11 November 2015
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 92 (1083) , 4-8
Haemorrhoids: modern diagnosis and treatment
Haemorrhoids present often to primary and secondary care, and haemorrhoidal procedures are among the most common carried out. They may co-exist with more serious pathology, and correct evaluation is important. In most cases a one-off colonoscopy in patients aged 50 or above with flexible sigmoidoscopy in younger patients is reasonable. Many people with haemorrhoids do not require treatment. Topical remedies provide no more than symptomatic relief—and even evidence for this is poor. Bulk laxatives alone may improve symptoms of both bleeding and prolapse and seem as effective as injection sclerotherapy. Rubber band ligation is effective in 75% of patients in the short term, but does not treat prolapsed haemorrhoids or those with a significant external component. Conventional haemorrhoidectomy remains the most effective treatment in the long term, the main limitation being post-operative pain. Metronidazole, topical sphincter relaxants and operative technique have all been shown to reduce pain. Stapled haemorrhoidectomy and haemorrhoidal artery ligation techniques are probably less effective but less painful. Long-term data are poor for all procedures, with many studies reporting only 1–3 years of follow-up data. Haemorrhoids are common in pregnancy, occurring in 40% of women. They can usually be treated conservatively during pregnancy, with any treatment delayed until after delivery. Acutely strangulated haemorrhoids may be treated either conservatively or operatively. There is an increased risk of anal stenosis after acute surgery, but the risks of sepsis and sphincter damage are less significant than previously thought. The majority of patients who are treated conservatively will still require definitive treatment at a later date.
- 11 November 2015
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 92 (1083) , 4-8
Haemorrhoids: modern diagnosis and treatment
Haemorrhoids present often to primary and secondary care, and haemorrhoidal procedures are among the most common carried out. They may co-exist with more serious pathology, and correct evaluation is important. In most cases a one-off colonoscopy in patients aged 50 or above with flexible sigmoidoscopy in younger patients is reasonable. Many people with haemorrhoids do not require treatment. Topical remedies provide no more than symptomatic relief—and even evidence for this is poor. Bulk laxatives alone may improve symptoms of both bleeding and prolapse and seem as effective as injection sclerotherapy. Rubber band ligation is effective in 75% of patients in the short term, but does not treat prolapsed haemorrhoids or those with a significant external component. Conventional haemorrhoidectomy remains the most effective treatment in the long term, the main limitation being post-operative pain. Metronidazole, topical sphincter relaxants and operative technique have all been shown to reduce pain. Stapled haemorrhoidectomy and haemorrhoidal artery ligation techniques are probably less effective but less painful. Long-term data are poor for all procedures, with many studies reporting only 1–3 years of follow-up data. Haemorrhoids are common in pregnancy, occurring in 40% of women. They can usually be treated conservatively during pregnancy, with any treatment delayed until after delivery. Acutely strangulated haemorrhoids may be treated either conservatively or operatively. There is an increased risk of anal stenosis after acute surgery, but the risks of sepsis and sphincter damage are less significant than previously thought. The majority of patients who are treated conservatively will still require definitive treatment at a later date.
- 22 June 2015
- Published by BMJ
- Vol. 64 (Suppl 1) , A152.2-A152
PTU-203 Hemorpex – effective and safe day case surgical treatment of haemorrhoids in a uk colorectal unit
Introduction The gold standard surgical option for symptomatic haemorrhoids remains haemorrhoidectomy due to its low recurrence rate but alternative options with less postoperative pain (and a slightly higher recurrence rate of around 10–20%) include stapled anopexy and haemorrhoidal artery ligation procedures. Hemorpex is a newer and cheaper technique in which arterial ligation is performed without the need for an expensive doppler probe. Previous studies have reported success rates of 70–90% with little postoperative pain. We present our first 3 years’ experience with this technique. Method Retrospective data were collected from hospital records on consecutive patients undergoing the Hemorpex procedure in a single centre over a 3 year period from June 2009 to June 2012. Patients under general or regional anaesthesia in the prone position had 6 spiral sutures placed in the 1, 3, 5, 7, 9 and 11 o’clock positions using the Hemorpex operating proctoscope. Skin tag excision was performed concurrently where appropriate. Demographic and outcome data were collected including admission, readmission, recurrence rates and postoperative complications. Results Some 248 patients underwent Hemorpex, as a day case in 94% of cases. The mean operating time was 27 min (SD 9.8 min). General anaesthesia (68%), spinal (30%) or caudal epidural (1%) were used. Early postoperative complications included acute urinary retention (4%), post-operative pain (3%) and minor post-operative bleeding (3%) none of whom required overnight admission. Nine percent required readmission, mostly for pain or bleeding. Fifteen percent presented with recurrence. Twelve percent required reintervention of whom half underwent redo Hemorpex or haemorrhoidectomy and a third required either office based treatment or skin tag excision. Conclusion Hemorpex is a successful day case technique for the surgical management of haemorrhoids with low morbidity and recurrence rate equivalent to similar procedures but without equivalent cost. Disclosure of interest None Declared.
- 22 June 2015
- Published by BMJ
- Vol. 64 (Suppl 1) , A152.2-A152
PTU-203 Hemorpex – effective and safe day case surgical treatment of haemorrhoids in a uk colorectal unit
Introduction The gold standard surgical option for symptomatic haemorrhoids remains haemorrhoidectomy due to its low recurrence rate but alternative options with less postoperative pain (and a slightly higher recurrence rate of around 10–20%) include stapled anopexy and haemorrhoidal artery ligation procedures. Hemorpex is a newer and cheaper technique in which arterial ligation is performed without the need for an expensive doppler probe. Previous studies have reported success rates of 70–90% with little postoperative pain. We present our first 3 years’ experience with this technique. Method Retrospective data were collected from hospital records on consecutive patients undergoing the Hemorpex procedure in a single centre over a 3 year period from June 2009 to June 2012. Patients under general or regional anaesthesia in the prone position had 6 spiral sutures placed in the 1, 3, 5, 7, 9 and 11 o’clock positions using the Hemorpex operating proctoscope. Skin tag excision was performed concurrently where appropriate. Demographic and outcome data were collected including admission, readmission, recurrence rates and postoperative complications. Results Some 248 patients underwent Hemorpex, as a day case in 94% of cases. The mean operating time was 27 min (SD 9.8 min). General anaesthesia (68%), spinal (30%) or caudal epidural (1%) were used. Early postoperative complications included acute urinary retention (4%), post-operative pain (3%) and minor post-operative bleeding (3%) none of whom required overnight admission. Nine percent required readmission, mostly for pain or bleeding. Fifteen percent presented with recurrence. Twelve percent required reintervention of whom half underwent redo Hemorpex or haemorrhoidectomy and a third required either office based treatment or skin tag excision. Conclusion Hemorpex is a successful day case technique for the surgical management of haemorrhoids with low morbidity and recurrence rate equivalent to similar procedures but without equivalent cost. Disclosure of interest None Declared.
- 22 May 2013
- Published by Wiley in Colorectal Disease
- Vol. 15 (9) , 1140-1144
Sacral nerve stimulation: an effective treatment for chronic functional anal pain?
Aim: Chronic idiopathic anal pain is a common condition of unknown aetiology. Patients may have co‐existing psychiatric disorders and existing treatments are often ineffective. A small number of published case reports suggest that sacral nerve stimulation (SNS) could treat this condition. This pilot study aimed to investigate the efficacy of SNS for the treatment of chronic anal pain.Method: Ten patients with chronic idiopathic anal pain were recruited. All had failed to respond to conservative treatments. Clinical and psychological evaluation was performed in all patients prior to SNS. Temporary stimulation of the S3 foramina was performed for 3 weeks and outcome assessed by comparison of a pain score diary and visual analogue score obtained during stimulation and at baseline. Primary outcome was defined as a > 50% reduction in pain score.Results: Of the 10 patients recruited, five were found to have clinical depression. Four patients withdrew from the study prior to testing and six underwent peripheral nerve evaluation (PNE). Three patients had > 50% reduction in pain score and progressed to permanent SNS. Of these, only one had good pain control at latest follow‐up of 5 years; the remaining two patients obtained no benefit and had their devices removed or deactivated. These two patients both had depression that was also not improved by SNS.Conclusion: This study would suggest that SNS is not an effective treatment for chronic anal pain in the majority of patients. PNE is not an effective means of identifying which of these patients are likely to respond to permanent SNS.
- 22 May 2013
- Published by Wiley in Colorectal Disease
- Vol. 15 (9) , 1140-1144
Sacral nerve stimulation: an effective treatment for chronic functional anal pain?
Aim: Chronic idiopathic anal pain is a common condition of unknown aetiology. Patients may have co‐existing psychiatric disorders and existing treatments are often ineffective. A small number of published case reports suggest that sacral nerve stimulation (SNS) could treat this condition. This pilot study aimed to investigate the efficacy of SNS for the treatment of chronic anal pain.Method: Ten patients with chronic idiopathic anal pain were recruited. All had failed to respond to conservative treatments. Clinical and psychological evaluation was performed in all patients prior to SNS. Temporary stimulation of the S3 foramina was performed for 3 weeks and outcome assessed by comparison of a pain score diary and visual analogue score obtained during stimulation and at baseline. Primary outcome was defined as a > 50% reduction in pain score.Results: Of the 10 patients recruited, five were found to have clinical depression. Four patients withdrew from the study prior to testing and six underwent peripheral nerve evaluation (PNE). Three patients had > 50% reduction in pain score and progressed to permanent SNS. Of these, only one had good pain control at latest follow‐up of 5 years; the remaining two patients obtained no benefit and had their devices removed or deactivated. These two patients both had depression that was also not improved by SNS.Conclusion: This study would suggest that SNS is not an effective treatment for chronic anal pain in the majority of patients. PNE is not an effective means of identifying which of these patients are likely to respond to permanent SNS.
- 9 January 2013
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (3) , 330-338
Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence
Background: Percutaneous, transcutaneous and sham transcutaneous posterior tibial nerve stimulation was compared in a prospective blinded randomized placebo‐controlled trial. Methods: Patients who had failed conservative treatment for faecal incontinence were randomized to one of three groups: group 1, percutaneous; group 2, transcutaneous; group 3, sham transcutaneous. Patients in groups 1 and 2 received 30‐min sessions of posterior tibial nerve stimulation twice weekly for 6 weeks. In group 3, transcutaneous electrodes were placed in position but no stimulation was delivered. Symptoms were measured at baseline and after 6 weeks using a bowel habit diary and St Mark's continence score. Response to treatment was defined as a reduction of at least 50 per cent in weekly episodes of faecal incontinence compared with baseline. Results: Thirty patients (28 women) were enrolled. Nine of 11 patients in group 1, five of 11 in group 2 and one of eight in group 3 had a reduction of at least 50 per cent in weekly episodes of faecal incontinence at the end of the 6‐week study phase (P = 0·035). Patients undergoing percutaneous nerve stimulation had a greater reduction in the number of incontinence episodes and were able to defer defaecation for a longer interval than those undergoing transcutaneous and sham stimulation. These improvements were maintained over a 6‐month follow‐up period. Conclusion: Posterior tibial nerve stimulation has short‐term benefits in treating faecal incontinence. Percutaneous therapy appears to have superior efficacy to stimulation applied by the transcutaneous route. Registration number: NCT00530933 (http://www.clinicaltrials.gov). Copyright © 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
- 9 January 2013
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 100 (3) , 330-338
Randomized controlled trial of percutaneous versus transcutaneous posterior tibial nerve stimulation in faecal incontinence
Background: Percutaneous, transcutaneous and sham transcutaneous posterior tibial nerve stimulation was compared in a prospective blinded randomized placebo‐controlled trial. Methods: Patients who had failed conservative treatment for faecal incontinence were randomized to one of three groups: group 1, percutaneous; group 2, transcutaneous; group 3, sham transcutaneous. Patients in groups 1 and 2 received 30‐min sessions of posterior tibial nerve stimulation twice weekly for 6 weeks. In group 3, transcutaneous electrodes were placed in position but no stimulation was delivered. Symptoms were measured at baseline and after 6 weeks using a bowel habit diary and St Mark's continence score. Response to treatment was defined as a reduction of at least 50 per cent in weekly episodes of faecal incontinence compared with baseline. Results: Thirty patients (28 women) were enrolled. Nine of 11 patients in group 1, five of 11 in group 2 and one of eight in group 3 had a reduction of at least 50 per cent in weekly episodes of faecal incontinence at the end of the 6‐week study phase (P = 0·035). Patients undergoing percutaneous nerve stimulation had a greater reduction in the number of incontinence episodes and were able to defer defaecation for a longer interval than those undergoing transcutaneous and sham stimulation. These improvements were maintained over a 6‐month follow‐up period. Conclusion: Posterior tibial nerve stimulation has short‐term benefits in treating faecal incontinence. Percutaneous therapy appears to have superior efficacy to stimulation applied by the transcutaneous route. Registration number: NCT00530933 (http://www.clinicaltrials.gov). Copyright © 2013 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.
- 7 September 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
Strangulated inguinal hernia presenting as haemoperitoneum
A 57-year-old man presented with abdominal pain following a collapse, with peritonism in his lower abdomen. He was haemodynamically stable, with haemoglobin of 12.6 g/dl. His significant medical history included open bilateral inguinal hernia repairs. CT demonstrated fluid within the abdominal cavity, and an area of stranding lying medially within the left iliac fossa. Ultra-sound guided fluid aspiration demonstrated frank blood. During admission, the patient noted a recurrence of his left inguinal hernia. Laparotomy revealed haemoperitoneum, and a haematoma arising in the left iliac fossa, walled off by mesentery of the sigmoid colon and adherent omentum. The open repair of the recurrent inguinal hernia identified the sac contents to be similar to the omentum. This association implies the omentum had herniated within the inguinal canal, tore or avulsed, resulting in haemorrhage from the proximal omental blood vessel resulting in haemoperitonism.
- 7 September 2012
- Published by BMJ in BMJ Case Reports
- Vol. 2012
Strangulated inguinal hernia presenting as haemoperitoneum
A 57-year-old man presented with abdominal pain following a collapse, with peritonism in his lower abdomen. He was haemodynamically stable, with haemoglobin of 12.6 g/dl. His significant medical history included open bilateral inguinal hernia repairs. CT demonstrated fluid within the abdominal cavity, and an area of stranding lying medially within the left iliac fossa. Ultra-sound guided fluid aspiration demonstrated frank blood. During admission, the patient noted a recurrence of his left inguinal hernia. Laparotomy revealed haemoperitoneum, and a haematoma arising in the left iliac fossa, walled off by mesentery of the sigmoid colon and adherent omentum. The open repair of the recurrent inguinal hernia identified the sac contents to be similar to the omentum. This association implies the omentum had herniated within the inguinal canal, tore or avulsed, resulting in haemorrhage from the proximal omental blood vessel resulting in haemoperitonism.
- 12 October 2011
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 43 (3) , 444-455
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients
The expression of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) is associated with poor prognosis in sporadic colorectal carcinoma (CRC). EGFR inhibitors are approved for the treatment of refractory CRC. The aim of this study was to investigate the expression of EGFR and HER2 and downstream extracellular signal regulated kinase (ERK) and mitogen activated protein kinase (MAPK) in non-neoplastic colonic mucosa, adenomas and carcinomas from familial adenomatous polyposis coli (FAP) patients, exploring the expression along the adenoma–carcinoma sequence.
- 12 October 2011
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 43 (3) , 444-455
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients
The expression of epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2) is associated with poor prognosis in sporadic colorectal carcinoma (CRC). EGFR inhibitors are approved for the treatment of refractory CRC. The aim of this study was to investigate the expression of EGFR and HER2 and downstream extracellular signal regulated kinase (ERK) and mitogen activated protein kinase (MAPK) in non-neoplastic colonic mucosa, adenomas and carcinomas from familial adenomatous polyposis coli (FAP) patients, exploring the expression along the adenoma–carcinoma sequence.
- 18 July 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (8) , e196-e202
Sacral nerve stimulation for faecal incontinence: optimizing outcome and managing complications
A knowledge of the principles of neurostimulation is essential to achieve optimal efficacy and minimize adverse effects. The aim of this article was to review the current evidence regarding device programming in the management of patients having sacral nerve stimulation (SNS) for faecal incontinence. A Medline search was performed including the keywords and/or MeSH headings of sacral nerve stimulation, neuromodulation, artificial pacemaker, faecal incontinence, programming, adverse effects and complications. Further studies were identified by cross-referencing from relevant articles and by appraisal of recent peer-reviewed conference abstracts and proceedings. Neurostimulator programming is an important component of SNS. Efficacy can be improved or restored with reprogramming. Adverse stimulation is often reversible, and nonstimulation-related complications are correctable. A total loss of efficacy can be explained in over one-half of patients. An improved outcome of SNS can be achieved by selecting the best possible stimulation parameters individualized to each patient. Further research into the optimal settings is needed.
- 18 July 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (8) , e196-e202
Sacral nerve stimulation for faecal incontinence: optimizing outcome and managing complications
A knowledge of the principles of neurostimulation is essential to achieve optimal efficacy and minimize adverse effects. The aim of this article was to review the current evidence regarding device programming in the management of patients having sacral nerve stimulation (SNS) for faecal incontinence. A Medline search was performed including the keywords and/or MeSH headings of sacral nerve stimulation, neuromodulation, artificial pacemaker, faecal incontinence, programming, adverse effects and complications. Further studies were identified by cross-referencing from relevant articles and by appraisal of recent peer-reviewed conference abstracts and proceedings. Neurostimulator programming is an important component of SNS. Efficacy can be improved or restored with reprogramming. Adverse stimulation is often reversible, and nonstimulation-related complications are correctable. A total loss of efficacy can be explained in over one-half of patients. An improved outcome of SNS can be achieved by selecting the best possible stimulation parameters individualized to each patient. Further research into the optimal settings is needed.
- 18 July 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (8) , e187-e195
Sacral nerve stimulation for faecal incontinence: patient selection, service provision and operative technique
Faecal incontinence is estimated to affect between 2 and 3% of Western adult populations. In recent years sacral nerve stimulation has become an important treatment modality, often as the first-line surgical therapy. The aim of this article was to review the current evidence regarding patient selection and surgical technique and to evaluate the logistics of providing a neurostimulation service. A Medline search was performed including the keywords and/or MeSH headings of sacral nerve stimulation, neuromodulation, artificial pacemaker, faecal incontinence, patient selection, predictive factors and anal canal. Further studies were identified by cross-referencing from relevant articles and by appraisal of recent peer-reviewed conference abstracts and proceedings. Despite the success of sacral nerve stimulation for several pathophysiological causes of incontinence, case selection is of paramount importance. Sacral nerve stimulation should not be offered outside a multidisciplinary pelvic floor unit. Temporary evaluation using diary cards can lead to false positive and negative results. Adherence to a meticulous surgical technique, using low amplitude stimulation to guide lead placement, provides optimal clinical outcome. The short-term outcome of sacral nerve stimulation is dependent on patient factors and operative technique. Despite this, specific preoperative predictive factors of treatment success have yet to be identified.
- 18 July 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (8) , e187-e195
Sacral nerve stimulation for faecal incontinence: patient selection, service provision and operative technique
Faecal incontinence is estimated to affect between 2 and 3% of Western adult populations. In recent years sacral nerve stimulation has become an important treatment modality, often as the first-line surgical therapy. The aim of this article was to review the current evidence regarding patient selection and surgical technique and to evaluate the logistics of providing a neurostimulation service. A Medline search was performed including the keywords and/or MeSH headings of sacral nerve stimulation, neuromodulation, artificial pacemaker, faecal incontinence, patient selection, predictive factors and anal canal. Further studies were identified by cross-referencing from relevant articles and by appraisal of recent peer-reviewed conference abstracts and proceedings. Despite the success of sacral nerve stimulation for several pathophysiological causes of incontinence, case selection is of paramount importance. Sacral nerve stimulation should not be offered outside a multidisciplinary pelvic floor unit. Temporary evaluation using diary cards can lead to false positive and negative results. Adherence to a meticulous surgical technique, using low amplitude stimulation to guide lead placement, provides optimal clinical outcome. The short-term outcome of sacral nerve stimulation is dependent on patient factors and operative technique. Despite this, specific preoperative predictive factors of treatment success have yet to be identified.
- 31 May 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (9) , e293-e296
Long‐term outcome of the use of botulinum toxin injection for functional anal pain
Aim Anal pain may occur in the absence of demonstrable anal pathology. Spasm of the sphincter muscles has been suggested as a cause in some patients. We aimed to assess the effectiveness of injection of botulinum toxin in treating this condition.Method Patients who had injection of botulinum toxin over a 3‐year period were identified retrospectively. Patients were excluded if anal fissure or other organic pathology was found to account for their symptoms on examination under anaesthetic. Long‐term outcome was assessed at a minimum 3‐year post‐procedure telephone follow up.Results Fourteen (eight male) patients were identified, of median age 50 years. Botulinum toxin (20–200 u) was injected into the internal sphincter. Seven of the 14 patients reported significant improvement in symptoms at 3 months. Seven were available for a structured telephone review at a median of 59 (42–68) months. The four patients who had benefited from the injection had remained asymptomatic.Conclusion Injection of botulinum toxin into the internal anal sphincter has a role in alleviating symptoms in a small proportion of patients with functional anal pain.
- 31 May 2011
- Published by Wiley in Colorectal Disease
- Vol. 13 (9) , e293-e296
Long‐term outcome of the use of botulinum toxin injection for functional anal pain
Aim Anal pain may occur in the absence of demonstrable anal pathology. Spasm of the sphincter muscles has been suggested as a cause in some patients. We aimed to assess the effectiveness of injection of botulinum toxin in treating this condition.Method Patients who had injection of botulinum toxin over a 3‐year period were identified retrospectively. Patients were excluded if anal fissure or other organic pathology was found to account for their symptoms on examination under anaesthetic. Long‐term outcome was assessed at a minimum 3‐year post‐procedure telephone follow up.Results Fourteen (eight male) patients were identified, of median age 50 years. Botulinum toxin (20–200 u) was injected into the internal sphincter. Seven of the 14 patients reported significant improvement in symptoms at 3 months. Seven were available for a structured telephone review at a median of 59 (42–68) months. The four patients who had benefited from the injection had remained asymptomatic.Conclusion Injection of botulinum toxin into the internal anal sphincter has a role in alleviating symptoms in a small proportion of patients with functional anal pain.